Helba İlaç is a prominent Turkish pharmaceutical company that focuses on the production and marketing of drugs across Turkey, the Balkans, CIS, and the Asia Pacific regions. Established by Welfar Pharma to advance its Sales and Marketing operations in Turkey, Helba has evolved into a key player in the pharmaceutical industry. In 2021, the company completed its state-of-the-art manufacturing facility in Istanbul, which adheres to stringent global quality standards. With an impressive annual production capacity of 75 million boxes of solid and semi-solid pharmaceuticals, Helba stands as a reliable partner for contract development and manufacturing in the sector.

Services include:
- Contract Development and Manufacturing (CDMO)
- Production of Active Pharmaceutical Ingredients
- Quality Assurance and Regulatory Affairs
- Product Development and Formulation Services
- Supply Chain Management
- Technical Support and Consultancy

Helba is committed to enhancing the health and well-being of individuals through its 'Health for Life' principle. For more information about Helba and its offerings, please visit helba.com.tr.